Releases & Statements

Washington, DC – Characterizing Senate passage of the Comprehensive Addiction and Recovery Act (CARA) as “a major victory for the nation’s long term care (LTC) pharmacy sector and the patients under their care,” the Senior Care Pharmacy Coalition (SCPC) today thanked key U.S. Senate and House leaders who helped shepherd-through a lengthy, complex legislative process, a vital provision that recognizes the key role played by LTC pharmacies in seniors’ medication management…Read More

Washington, DC – In thanking the Food and Drug Administration (FDA) for holding a recent listening session regarding provisions of the Drug Quality and Security Act (DQSA), Senior Care Pharmacy Coalition (SCPC) President and CEO, Alan G. Rosenbloom, said the gathering served as a productive forum to reiterate the need for FDA to ensure its implementation does not inadvertently create unanticipated burdens on dispensing practices in specialized settings like LTC facilities and pharmacies…Read More

Placed on the defensive by a growing level of congressional scrutiny and unfavorable publicity surrounding lawsuits against the shadowy pharmacy benefit manager (PBM) industry, the Senior Care Pharmacy Coalition (SCPC) noted the Pharmaceutical Care Management Association (PCMA) is being forced to mount a defensive public relations effort to counter the growing perception that PBMs are anti-consumer, anti-taxpayer and anti-free market….Read More

Washington, DC — In praising today’s Senate passage of the Comprehensive Addiction and Recovery Act (CARA), the Senior Care Pharmacy Coalition (SCPC) thanked Senators Rob Portman (R-OH), Kelly Ayotte (R-NH), Mark Kirk (R-IL), Sheldon Whitehouse (D-RI), Amy Klobuchar (D-MN) and Christopher Coons (D-DE) and their colleagues in the U.S. Senate for helping place the nation’s opioid abuse epidemic front and center in the public spotlight…Read More

In response to the Centers for Medicare and Medicaid Service’s (CMS) draft 2017 Part D Call letter, the Senior Care Pharmacy Coalition (SCPC) urged still more rigorous efforts to ensure greater prescription drug plan (PDP) transparency in regard to Maximum Allowable Cost (MAC) pricing – despite a recent CMS initiative to do so…Read More

The Senior Care Pharmacy Coalition (“SCPC”) appreciates the opportunity to provide the following comments to the Center for Medicare and Medicaid Service’s (“CMS”) draft 2017 Part D Call Letter, dated February 19, 2016 (the “Call Letter”)….Read More

The Senior Care Pharmacy Coalition (SCPC) today praised U.S. Reps. Doug Collins (R-GA) and Dave Loebsack (D-IA) for issuing a letter with fourteen colleagues urging the Chairmen of the U.S. House Energy and Commerce, Ways and Means and Armed Services Committees to examine the importance of passing the MAC Transparency Act (H.R. 244) in advancing payment transparency in regard to how Pharmacy Benefit Managers (PBMs) reimburse a variety of pharmacy groups, including LTC pharmacies, for generic drugs administered to patients…Read More

Washington, DC — With former Turing Pharmaceuticals CEO Martin Shkreli significantly raising the public profile of prescription drug pricing abuses, the Senior Care Pharmacy Coalition (SCPC) is stepping up its criticism of anti-competitive pharmacy benefit manager (PBM) pricing practices by pointing to Avalere Health pharmacy data, which SCPC argues demonstrates PBMs’ pricing methodology leads to arbitrary and capricious reimbursement – warranting greater Congressional scrutiny and oversight in 2016…Read More

The Senior Care Pharmacy Coalition (SCPC) today commended House Oversight and Government Reform Committee Chairman Jason Chaffetz (R-UT) and Ranking Member Elijah Cummings (D-MD) for holding today’s hearing, “Developments in the Prescription Drug Market,” to examine exorbitant drug price increases and growing questions about abusive pharmacy benefit manager (PBM) pricing practices…Read More